世界のファーマコゲノミクス(PGx)市場2020:企業別、地域別、種類別、用途別、市場予測2025

GlobalInfoResearchが発行した調査報告書(GIR20OC08081)
◆英語タイトル:Global Pharmacogenomics (PGx) Market 2020 by Company, Regions, Type and Application, Forecast to 2025
◆商品コード:GIR20OC08081
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2020年10月(※2024年版があります。お問い合わせください。)
◆ページ数:120
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:機械・機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本書では、ファーマコゲノミクス(PGx)の世界市場を調査対象にし、ファーマコゲノミクス(PGx)の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析(北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ)、種類別分析(ポリメラーゼ連鎖反応(PCR)、マイクロアレイ、シーケンシング、その他)、用途別分析(心血管疾患(CVD)、中枢神経系(CNS)、癌/腫瘍学、感染症、その他)、市場予測(2021年~2025年)情報などを整理しました。
・市場概要
・企業情報:Abbott Laboratories、Myriad Genetics, Inc.、Astrazeneca、Affymetrix, Inc.、Laboratory Corporation of America Holdings、Assurex Health, Inc、Pfizer, Inc、Illumina, Inc.、GeneDX、Pathway Genomics、Transgenomic, Inc.、Qiagen, Inc.、Thermo Fisher Scientific、Rocheg、Teva Pharmaceutical Industries Ltd.
・企業別売上、市場シェア
・ファーマコゲノミクス(PGx)の地域別市場分析
・ファーマコゲノミクス(PGx)の北米市場規模2015-2020:アメリカ、カナダ、メキシコ
・ファーマコゲノミクス(PGx)のヨーロッパ市場規模2015-2020:ドイツ、イギリス、フランス、ロシアなど
・ファーマコゲノミクス(PGx)のアジア市場規模2015-2020:日本、中国、韓国、インド、東南アジアなど
・ファーマコゲノミクス(PGx)の南米市場規模2015-2020:ブラジル、アルゼンチンなど
・ファーマコゲノミクス(PGx)の中東・アフリカ市場規模2015-2020:サウジアラビア、トルコ、エジプト、南アフリカなど
・ファーマコゲノミクス(PGx)の種類別市場規模2015-2020:ポリメラーゼ連鎖反応(PCR)、マイクロアレイ、シーケンシング、その他
・ファーマコゲノミクス(PGx)の用途別市場規模2015-2020:心血管疾患(CVD)、中枢神経系(CNS)、癌/腫瘍学、感染症、その他
・ファーマコゲノミクス(PGx)の世界市場予測2021-2025:地域別、種類別、用途別
・調査の結果・結論
【レポートの概要】

Market Overview
The global Pharmacogenomics (PGx) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Pharmacogenomics (PGx) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Pharmacogenomics (PGx) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Pharmacogenomics (PGx) market has been segmented into:
Polymerase Chain Reaction (PCR)
Microarray
Sequencing
Other

By Application, Pharmacogenomics (PGx) has been segmented into:
Cardiovascular Diseases (CVD)
Central Nervous System (CNS)
Cancer/Oncology
Infectious Diseases
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pharmacogenomics (PGx) market presented in the report. This section sheds light on the sales growth of different regional and country-level Pharmacogenomics (PGx) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pharmacogenomics (PGx) market.

The report offers in-depth assessment of the growth and other aspects of the Pharmacogenomics (PGx) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Pharmacogenomics (PGx) Market Share Analysis
Pharmacogenomics (PGx) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pharmacogenomics (PGx) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pharmacogenomics (PGx) sales, revenue and market share for each player covered in this report.

The major players covered in Pharmacogenomics (PGx) are:
Abbott Laboratories
Myriad Genetics, Inc.
Astrazeneca
Affymetrix, Inc.
Laboratory Corporation of America Holdings
Assurex Health, Inc
Pfizer, Inc
Illumina, Inc.
GeneDX
Pathway Genomics
Transgenomic, Inc.
Qiagen, Inc.
Thermo Fisher Scientific
Rocheg
Teva Pharmaceutical Industries Ltd.

【レポートの目次】

1 Pharmacogenomics (PGx) Market Overview
1.1 Product Overview and Scope of Pharmacogenomics (PGx)
1.2 Classification of Pharmacogenomics (PGx) by Type
1.2.1 Global Pharmacogenomics (PGx) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Pharmacogenomics (PGx) Revenue Market Share by Type in 2019
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Microarray
1.2.5 Sequencing
1.2.6 Other
1.3 Global Pharmacogenomics (PGx) Market by Application
1.3.1 Overview: Global Pharmacogenomics (PGx) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cardiovascular Diseases (CVD)
1.3.3 Central Nervous System (CNS)
1.3.4 Cancer/Oncology
1.3.5 Infectious Diseases
1.3.6 Other
1.4 Global Pharmacogenomics (PGx) Market by Regions
1.4.1 Global Pharmacogenomics (PGx) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Pharmacogenomics (PGx) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pharmacogenomics (PGx) Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.2 Myriad Genetics, Inc.
2.2.1 Myriad Genetics, Inc. Details
2.2.2 Myriad Genetics, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Myriad Genetics, Inc. SWOT Analysis
2.2.4 Myriad Genetics, Inc. Product and Services
2.2.5 Myriad Genetics, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astrazeneca
2.3.1 Astrazeneca Details
2.3.2 Astrazeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astrazeneca SWOT Analysis
2.3.4 Astrazeneca Product and Services
2.3.5 Astrazeneca Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.4 Affymetrix, Inc.
2.4.1 Affymetrix, Inc. Details
2.4.2 Affymetrix, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Affymetrix, Inc. SWOT Analysis
2.4.4 Affymetrix, Inc. Product and Services
2.4.5 Affymetrix, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.5 Laboratory Corporation of America Holdings
2.5.1 Laboratory Corporation of America Holdings Details
2.5.2 Laboratory Corporation of America Holdings Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Laboratory Corporation of America Holdings SWOT Analysis
2.5.4 Laboratory Corporation of America Holdings Product and Services
2.5.5 Laboratory Corporation of America Holdings Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.6 Assurex Health, Inc
2.6.1 Assurex Health, Inc Details
2.6.2 Assurex Health, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Assurex Health, Inc SWOT Analysis
2.6.4 Assurex Health, Inc Product and Services
2.6.5 Assurex Health, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.7 Pfizer, Inc
2.7.1 Pfizer, Inc Details
2.7.2 Pfizer, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Pfizer, Inc SWOT Analysis
2.7.4 Pfizer, Inc Product and Services
2.7.5 Pfizer, Inc Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.8 Illumina, Inc.
2.8.1 Illumina, Inc. Details
2.8.2 Illumina, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Illumina, Inc. SWOT Analysis
2.8.4 Illumina, Inc. Product and Services
2.8.5 Illumina, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.9 GeneDX
2.9.1 GeneDX Details
2.9.2 GeneDX Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 GeneDX SWOT Analysis
2.9.4 GeneDX Product and Services
2.9.5 GeneDX Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pathway Genomics
2.10.1 Pathway Genomics Details
2.10.2 Pathway Genomics Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pathway Genomics SWOT Analysis
2.10.4 Pathway Genomics Product and Services
2.10.5 Pathway Genomics Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.11 Transgenomic, Inc.
2.11.1 Transgenomic, Inc. Details
2.11.2 Transgenomic, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Transgenomic, Inc. SWOT Analysis
2.11.4 Transgenomic, Inc. Product and Services
2.11.5 Transgenomic, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.12 Qiagen, Inc.
2.12.1 Qiagen, Inc. Details
2.12.2 Qiagen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Qiagen, Inc. SWOT Analysis
2.12.4 Qiagen, Inc. Product and Services
2.12.5 Qiagen, Inc. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.13 Thermo Fisher Scientific
2.13.1 Thermo Fisher Scientific Details
2.13.2 Thermo Fisher Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Thermo Fisher Scientific SWOT Analysis
2.13.4 Thermo Fisher Scientific Product and Services
2.13.5 Thermo Fisher Scientific Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.14 Rocheg
2.14.1 Rocheg Details
2.14.2 Rocheg Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Rocheg SWOT Analysis
2.14.4 Rocheg Product and Services
2.14.5 Rocheg Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
2.15 Teva Pharmaceutical Industries Ltd.
2.15.1 Teva Pharmaceutical Industries Ltd. Details
2.15.2 Teva Pharmaceutical Industries Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Teva Pharmaceutical Industries Ltd. SWOT Analysis
2.15.4 Teva Pharmaceutical Industries Ltd. Product and Services
2.15.5 Teva Pharmaceutical Industries Ltd. Pharmacogenomics (PGx) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pharmacogenomics (PGx) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Pharmacogenomics (PGx) Players Market Share
3.2.2 Top 10 Pharmacogenomics (PGx) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Pharmacogenomics (PGx) Revenue and Market Share by Regions
4.2 North America Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
4.3 Europe Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
4.5 South America Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
5 North America Pharmacogenomics (PGx) Revenue by Countries
5.1 North America Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
5.2 USA Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
5.3 Canada Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
5.4 Mexico Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6 Europe Pharmacogenomics (PGx) Revenue by Countries
6.1 Europe Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
6.2 Germany Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6.3 UK Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6.4 France Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6.5 Russia Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
6.6 Italy Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Pharmacogenomics (PGx) Revenue by Countries
7.1 Asia-Pacific Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
7.2 China Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7.3 Japan Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7.4 Korea Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7.5 India Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
8 South America Pharmacogenomics (PGx) Revenue by Countries
8.1 South America Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
8.2 Brazil Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
8.3 Argentina Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Pharmacogenomics (PGx) by Countries
9.1 Middle East & Africa Pharmacogenomics (PGx) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
9.3 UAE Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
9.4 Egypt Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
9.5 South Africa Pharmacogenomics (PGx) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Pharmacogenomics (PGx) Revenue and Market Share by Type (2015-2020)
10.2 Global Pharmacogenomics (PGx) Market Forecast by Type (2019-2024)
10.3 Polymerase Chain Reaction (PCR) Revenue Growth Rate (2015-2025)
10.4 Microarray Revenue Growth Rate (2015-2025)
10.5 Sequencing Revenue Growth Rate (2015-2025)
10.6 Other Revenue Growth Rate (2015-2025)
11 Global Pharmacogenomics (PGx) Market Segment by Application
11.1 Global Pharmacogenomics (PGx) Revenue Market Share by Application (2015-2020)
11.2 Pharmacogenomics (PGx) Market Forecast by Application (2019-2024)
11.3 Cardiovascular Diseases (CVD) Revenue Growth (2015-2020)
11.4 Central Nervous System (CNS) Revenue Growth (2015-2020)
11.5 Cancer/Oncology Revenue Growth (2015-2020)
11.6 Infectious Diseases Revenue Growth (2015-2020)
11.7 Other Revenue Growth (2015-2020)
12 Global Pharmacogenomics (PGx) Market Size Forecast (2021-2025)
12.1 Global Pharmacogenomics (PGx) Market Size Forecast (2021-2025)
12.2 Global Pharmacogenomics (PGx) Market Forecast by Regions (2021-2025)
12.3 North America Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
12.4 Europe Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
12.6 South America Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Pharmacogenomics (PGx) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界のファーマコゲノミクス(PGx)市場2020:企業別、地域別、種類別、用途別、市場予測2025(Global Pharmacogenomics (PGx) Market 2020 by Company, Regions, Type and Application, Forecast to 2025)]についてメールでお問い合わせはこちらでお願いします。